Whanin Pharm Co (XKRX:016580) Other Operating Expense : ₩31,668 Mil (TTM As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Whanin Pharm Co Other Operating Expense?

Whanin Pharm Co's Other Operating Expense for the three months ended in Mar. 2024 was ₩7,494 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩31,668 Mil.

Whanin Pharm Co's quarterly Other Operating Expense declined from Sep. 2023 (₩8,157 Mil) to Dec. 2023 (₩7,967 Mil) and declined from Dec. 2023 (₩7,967 Mil) to Mar. 2024 (₩7,494 Mil).

Whanin Pharm Co's annual Other Operating Expense declined from Dec. 2021 (₩30,478 Mil) to Dec. 2022 (₩30,361 Mil) but then increased from Dec. 2022 (₩30,361 Mil) to Dec. 2023 (₩31,500 Mil).

Whanin Pharm Co Other Operating Expense Historical Data

The historical data trend for Whanin Pharm Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Whanin Pharm Co Other Operating Expense Chart

Whanin Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

28,456.98

29,298.83

30,478.44

30,360.50

31,499.68

Whanin Pharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															7,325.98	8,050.13	8,156.82	7,966.76	7,494.48

Whanin Pharm Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩31,668 Mil.

Whanin Pharm Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Whanin Pharm Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Whanin Pharm Co (XKRX:016580) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Whanin Pharm Co Ltd (XKRX:016580) » Definitions » Other Operating Expense

Traded in Other Exchanges

N/A

Address

84-1 Munjeong-dong, Songpa-gu, Seoul, KOR, 138-200

Website

http://www.whanin.co.kr

Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.

Whanin Pharm Co (XKRX:016580) Headlines

No Headlines